FDA RSABE is ISC [R for BE/BA]

posted by Helmut Homepage – Vienna, Austria, 2020-07-16 09:11 (106 d 04:26 ago) – Posting: # 21709
Views: 8,920

Hi Detlew,

» Why not use the ISC estimate of T-R in the ABE decision in case of swR < 0.029356 (CVwR < 30%)?
» Politics? Nostalgia (Since years recommended the Proc MIXED code)?

The guidance “Statistical Approaches to Establishing Bioequivalence” of January 2001 (where the same SAS code is given in APPENDIX E) is still in force. Hence, it is only consistent to give it in the progesterone guidance.

» I would opt for the full ISC approach because it may be unambiguously implemented in SAS, R, Phoenix and so on for every replicate design, full or partial :cool:.

Cannot agree more. All problems would vanish.

Dif-tor heh smusma 🖖
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

Activity
 Admin contact
21,180 posts in 4,415 threads, 1,476 registered users;
online 4 (0 registered, 4 guests [including 2 identified bots]).
Forum time: Friday 13:37 UTC (Europe/Vienna)

The idea is to try and give all the information to help others
to judge the value of your contribution;
not just the information that leads to judgment
in one particular direction or another.    Richard Feynman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5